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Summary
Background:Transrectal ultrasound is commonly performed in the
clinical evaluation of the prostate. Ultrasound-guided randomized
sextant biopsy became the standard procedure for the diagnosis
of carcinoma of the prostate (CaP). A guided biopsy of sono-
graphically irregular lesions of the prostate is not performed in
randomized biopsies. An almost generally accepted opinion is that
hypoechoic lesions are suspicious for the presence of CaP. How-
ever, the role of prostatic lesions with an echogenicity other than
iso- or hypoechoic, e.g. hyperechoic or irregular lesions in relation
to CaP is not clear. The intention of the present prospective study
was to clarify the role of different prostatic ultrasound findings
with a new-generation ultrasound probe in regard to their rele-
vance concerning the presence of cancer. Material and Methods:
265 patients who were referred for prostatic evaluation because of
an elevated PSA serum level or a positive digital rectal examina-
tion were enrolled in a prospective study. All patients had a sys-
tematic ultrasound-guided sextant biopsy of the prostate and a 
4-core biopsy of the transition zone. All biopsy cores taken were
guided by transrectal ultrasound. In case of a sonographically
suspicious lesion, biopsy was always directed into this area. The
predominant ultrasound appearance was separately recorded for
each core. Results: Carcinoma of the prostate was detected in 87
(32.8%) of the 265 patients. Biopsy cores with isoechoic ultrasound
findings revealed CaP in 7.6%. The data for hypoechoic, hyper-
echoic, mixed-echoic and anechoic lesions were 34.5, 26.9, 21.1
and 0%, respectively. Hypoechoic ultrasound findings were less
frequently found in the transition zone of the prostate, but the rate
of CaP detection was the same as in the peripheral zone of the
prostate. Conclusions: The transrectal ultrasound pattern of the
prostate yields important information about the presence of carci-
noma of the prostate. Especially hypoechoic lesions indicate the
presence of CaP in a significant proportion of cases. However,
hyperechoic lesions and lesions of mixed or irregular echogenicity
were found to contain cancer in significant numbers as well, and
should therefore be considered to be suspicious for cancer when
performing transrectal ultrasound of the prostate. Directed biopsy
of irregular ultrasound patterns in the prostate seems therefore to
be recommendable.
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Zusammenfassung
Hintergrund: Der transrektale Ultraschall ist die häufigste bild-
gebende Untersuchung zur klinischen Beurteilung der Prostata.
Zur Diagnostik des Prostatakarzinoms (PCa) hat sich die ultra-
schallgesteuerte Sextanten-Biopsie als Standardverfahren eta-
bliert. Eine gezielte Biopsie irregulärer Ultraschallbezirke ist hier
nicht vorgesehen. Es ist jedoch bekannt, daß sonographisch
echoarm erscheinende Areale suspekt für die Präsenz eines PCa
sind. Die Wertigkeit nicht einheitlicher oder echoreicher Ultraschall-
muster ist jedoch bisher nicht zweifelsfrei geklärt. Ziel der vor-
liegenden Arbeit war es, mit einem Ultraschallgerät der neuesten
Generation die Bedeutung der verschiedenen Ultraschallmuster
bezüglich des Vorhandenseins von Prostatakarzinomen zu klären.
Material und Methoden: 265 Patienten mit erhöhten PSA-Serum-
werten oder suspekten Tastbefunden der Prostata wurden in die
prospektive Untersuchung eingeschlossen. Bei allen Patienten
wurden systematische, ultraschallgesteuerte Prostatabiopsien,
wie in der Sextantenbiopsie vorgesehen, und 4 Zylinder aus der
Transitionalzone entnommen. Bei der Biopsie wurde jedoch
gezielt die Punktion in Bereichen von – falls vorhanden – irre-
gulärem Ultraschallmuster vorgenommen und das entsprechende
Ultraschallbild dokumentiert. Ergebnisse: Bei 87 der 265 Patienten
(32,8%) wurden Prostatakarzinome nachgewiesen. Biopsiezylinder
aus isodensen Bereichen wiesen in 7,6% ein Prostatakarzinom auf.
Die Karzinomhäufigkeit bei Biopsie von echoarmen und echo-
reichen Arealen sowie von Arealen mit unterschiedlichen Echo-
mustern und von zystischen Arealen wurde mit 34,5, 26,9, 21,1
bzw. 0% ermittelt. Echoarme Befunde wurden seltener in der Tran-
sitionalzone nachgewiesen, waren jedoch dort in etwa gleicher
Häufigkeit mit einem Karzinom verbunden wie in der peripheren
Zone. Schlußfolgerungen: Das transrektale Ultraschallmuster in
der Prostata liefert wichtige Hinweise auf das Vorhandensein eines
Prostatakarzinoms. Insbesondere echoarme Läsionen deuten 
auf ein PCa hin. Echoreiche Läsionen und solche mit unterschied-
lichen Echomustern enthielten jedoch Karzinome in so bedeu-
tender Anzahl, daß diese Läsionen ebenfalls als karzinomverdäch-
tig eingestuft werden müssen und auch eine gezielte Biopsie
dieser Areale im Rahmen der Sextantenbiopsie empfehlenswert
erscheint.
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Introduction
In the early 1980s, cancer of the prostate (CaP) was believed 
to have a hyperechoic appearance in transrectal ultrasound
(TRUS) [1–3]. In 1985, Lee and co-workers [4], however,
demonstrated that CaP in the peripheral zone has a predomi-
nantly hypoechoic ultrasound pattern. These findings were
confirmed by other investigators [5, 6]. In the meantime,
further technical (ultrasound consoles) and diagnostic impro-
vements (TRUS-guided biopsy, systematic sextant biopsy,
transition zone biopsy) were made. Especially PSA-based
screening programs led to an increase in the number of CaPs
detected and to an increase of patients subjected to biopsy.This
resulted in a stage shift from more advanced CaP towards T2
and nonpalpable T1c CaP. However, there is a large number of
patients with benign histologies on systematic sextant biopsies
of the peripheral zone (65.6–82.1%) [7, 8]. In such cases, further
biopsies may reveal the presence of CaP in up to 21% accord-
ing to Keetch et al. [9].A more differentiated use of biopsy tech-
niques with ultrasound diagnostic could be helpful in reducing
the number of unnecessary (primary and further) prostatic
biopsies and would increase the number of CaPs detected.
Therefore, in the present prospective study all isoechoic and
suspicious lesions in peripheral and transition zone TRUS
were analyzed in relation to the rate of CaPs detected.
Materials and Methods
Between September 1997 and July 1999, 265 men referred for systematic
prostate biopsy were included in this prospective study. Indications for
prostate biopsy were an elevation of the PSA value in serum (PSA ‡ 4 ng/
ml; n = 238) and/or a digital rectal examination (DRE) suspicious for CaP
(n = 99). Serum PSA levels were determined before any rectal manipula-
tions with the Abbott AxSym enzyme immunoassay (Abbott, Wiesbaden,
Germany).DRE was performed,and the findings were classified as benign,
benignly enlarged or suspect. Urinary examination was carried out in all
patients. Patients with urinary tract infections were treated by antibiotics
corresponding to urinary culture and sensitivity testing.The prostate biopsy
was postponed in all cases of urinary tract infections. In all other patients,
ciprofloxacin (2 · 250 mg b.d.) was administered for 5 days as a prophy-
lactic antibiotic treatment, beginning 2 days before the biopsy. Careful
counseling relative to the possible complications was carried out, and both
verbal and written consent was obtained. All men underwent real-time
transrectal ultrasound using a Siemens Versa (7.5-MHz biplanar) ultra-
sound probe (Siemens, Erlangen, Germany). Each prostate was examined
in sagittal and axial projections. The distinction between peripheral and
transition zones was recognizable in all cases. Core biopsies were obtained
using an automatic biopsy device (Urotech, Bruckmühl, Germany). From
each lobe 5 cores were taken: 3 cores from the peripheral zone (apex, mid-
gland and base of the prostate) according to the systematic sextant biopsy
technique described previously by Hodge et al. [10], and 2 from the transi-
tion zone. If there was a suspicious ultrasound finding, the biopsy needle
was directed into this area. For each core taken, the predominant ultra-
sound pattern was recorded and classified as isoechoic, hypoechoic, hyper-
echoic or anechoic. Areas of non-uniform ultrasound patterns were clas-
sified as mixed-echoic. Biopsy specimens were processed separately and
evaluated for the presence of CaP. All tumors were classified according to
the TNM classification of 1997 [11].
Statistical analysis was carried out with ‘SPSS for Windows’ 8.0. Distribu-
tion of variance was tested with the chi-square test. A univariate ANOVA
was done, and differences in means were analyzed with the Scheffé and
Tamhane procedure. The level of significance was set at 5% probability 
of error.
Results
The mean PSA serum level of all patients was 40.89 (median
8.3) ng/ml, with a range of 0.4 to 3,773 ng/ml. Histological
examination was done in all cases and revealed the presence of
CaP in 87 of 265 patients (32.8%).Tumor stages were classified
as T1c (n =19), T2 (n = 43), T3 (n =18), and T4 (n = 7). Accord-
ing to the TNM classification of 1997, 20 of the 43 T2 tumors
had a negative rectal finding but TRUS was suspicious for CaP,
and 23 patients had a positive DRE. In the 87 patients with
CaP, 4.02 core biopsies were positive on average (range 1–10).
In 27 patients (31%), CaP was present in the peripheral zone
only. In 5 patients (5.8%), CaP was histologically confirmed in
the transition zone only, and 55 cancers (63.2%) were found in
both peripheral and transition zones.
The results of the ultrasonographic examination and the cor-
responding histological findings for each biopsy core are pre-
sented in table 1. Biopsies taken from tissue with isoechoic
pattern revealed CaP in 7.6% of cases only, whereas a hypo-
echoic lesion was associated with CaP in 34.5% of all biopsy
cores. In addition, biopsy cores taken from regions with hyper-
echoic or mixed-echoic appearance were also connected with
the presence of CaP in a significant proportion (26.9 and
21.1%, respectively). In contrast, biopsies taken from cystic
lesions never revealed CaP (table 1).
Regarding statistical analysis, a significant correlation between
histological result (benign histology, prostatic intraepithelial
neoplasia (PIN), CaP) and ultrasound appearance of the
prostatic tissue biopsied was found (chi-square test p = 0.000,
X2 = 245.72; contingency coefficient = 0.291).
Univariate analysis of variance showed also a significant dif-
ference in mean group values for histology and for the number
of different ultrasound findings (isoechoic, hypoechoic, hyper-
echoic, mixed-echoic, anechoic).
The Scheffé and Tamhane procedure showed also a significant
difference for mean values for histologically benign and CaP
results (p = 0.000), but not for PIN findings (p = 0.849).
In tables 2 and 3 the results for the patients with positive or
negative DRE are demonstrated. A significant correlation be-
tween histological results and ultrasound patterns was found 
in patients with suspicious DRE (chi-square test p = 0.000,
X2 = 259.51; contingency coefficient = 0.308). Univariate ana-
lysis of variance showed a significant difference in mean group
values for the benign histology, PIN and CaP for the number of
different ultrasound findings (p = 0.000) (table 2). The Scheffé
and Tamhane procedure gave a statistically significant dif-
ference for mean values for histologically benign and CaP
results (p = 0.000), but not for PIN findings (p = 0.703) (table 2).
The chi-square test could not be applied for patients with nega-
tive DRE (table 3), as there were more than 20% of predicted
values below 5 (X2 = 37.81; contingency coefficient = 0.149 for
patients with negative rectal findings). In addition, the uni-
variate analysis of variance did not show a significant difference
in mean group values (p = 0.824) (table 3).
The results of the 130 patients (49.1%) with hypoechoic lesions
in the transrectal ultrasound examination are presented in
table 4. These were detected in the peripheral zone in 70 cases,
in the transition zone in 23 cases, and in both peripheral and
transition zones in 37 cases. In 54 of the 130 patients with
Ultrasound Findings in the Prostate Suspicious 
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Histological Ultrasonographical tissue appearance (all patients)
result isodense hypoechoic hyperechoic mixed-echoic anechoic total
Benign
Biopsy cores
Number 1,559 188 168 166 127 2,208
Expected*, n 1,460.6 255.8 195.0 185.8 110.8 2,208.0
Histology, % 70.6 8.5 7.6 7.5 5.8 100.0
Ultrasound, % 88.9 61.2 71.8 74.4 95.5 83.3
PIN
Biopsy cores
Number 60 13 3 10 6 92
Expected*, n 60.9 10.7 8.1 7.7 4.6 92.0
Histology, % 65.2 14.1 3.3 10.9 6.5 100.0
Ultrasound, % 3.4 4.2 1.3 4.5 4.5 3.5
CaP
Biopsy cores
Number 134 106 63 47 0 350
Expected*, n 231.5 40.5 30.9 29.5 17.6 350.0
Histology, % 38.3 30.3 18.0 13.4 0.0 100.0
Ultrasound, % 7.6 34.5 26.9 21.1 0.0 13.2
Total
Biopsy cores
Number 1,753 307 234 223 133 2,650
Expected*, n 1,753.0 307.0 234.0 223.0 133.0 2,650.0
Histology, % 66.2 11.6 8.8 8.4 5.0 100.0
Ultrasound, % 100.0 100.0 100.0 100.0 100.0 100.0
*Expected by chi-square test.
Table 1. Results of each core biopsy of the
prostate in relation to the sonographically
determined appearance of the area biopsied 
in correlation to statistical analysis 
(chi-square test)
Histological Ultrasonographical tissue appearance in patients with positive DRE (n = 99)
result isodense hypoechoic hyperechoic mixed-echoic anechoic total
Benign
Biopsy cores
Number 422 90 96 61 29 698
Expected*, n 365.9 128.3 110.0 72.6 21.2 698.0
Histology, % 60.5 12.9 13.8 8.7 4.2 100.0
Ultrasound, % 81.3 49.5 61.5 59.2 96.7 70.5
PIN
Biopsy cores
Number 12 2 2 5 1 22
Expected*, n 11.5 4.0 3.5 2.3 0.7 22.0
Histology, % 54.5 9.1 9.1 22.7 4.5 100.0
Ultrasound, % 2.3 1.1 1.3 4.9 3.3 2.2
CaP
Biopsy cores
Number 85 90 58 37 0 270
Expected*, n 141.5 49.6 42.5 28.1 8.2 270.0
Histology, % 31.5 33.3 21.5 13.7 0.0 100.0
Ultrasound, % 16.4 49.5 37.2 35.9 0.0 27.3
Total
Biopsy cores
Number 519 182 156 103 30 990
Expected*, n 519.0 182.0 156.0 103.0 30.0 990.0
Histology, % 52.4 18.4 15.8 10.4 3.0 100.0
Ultrasound, % 100.0 100.0 100.0 100.0 100.0 100.0
*Expected by chi-square test.
Table 2. Results of each core biopsy of the
prostate of patients with positive findings in
DRE in relation to the sonographically deter-
mined appearance of the area biopsied in cor-
relation to statistical analysis (chi-square test)
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hypoechoic lesions, a CaP was detected. In 45 of these 54 pa-
tients, CaP was histologically confirmed in hypoechoic lesions,
and in 9 of the 54 patients the localization of the CaP was other
than in the hypoechoic lesion. The presence of a hypoechoic
lesion in the peripheral or transition zone only was associated
with a CaP in a corresponding biopsy core in 29.7% and 20%,
respectively. If hypoechoic lesions were present in both pe-
ripheral and transition zones, a CaP was detected in 59.5%.The
mean number of biopsy cores with a hypoechoic ultrasound
pattern was 0.84 ±1.3 in patients with a benign histology vs
1.8 ±1.98 in patients with CaP. In all patients with CaP, an
average of 4.2 biopsy cores was taken from suspicious lesions
(hypoechoic, hyperechoic or mixed-echoic) (fig. 1). In patients
with benign histology, only 2.2 biopsy cores showed sonogra-
phically suspicious lesions.
Discussion
Randomized sextant biopsy of the prostate as described by
Hodge et al. [10] in 1989 was established as the standard
diagnostic procedure in the evaluation of patients with the
suspicion of CaP. However, as many as 41.5% of significant
CaPs may be missed by one set of prostatic biopsies, as could
be demonstrated by Djavan et al. [12] who performed two
consecutive sets of prostatic biopsies in a group of 1,051 pa-
tients (PSA serum levels 4–10 ng/ml). Efforts have therefore
been made to improve the detection rate of the systematic
sextant biopsy of the prostate and to reduce the number of
secondary prostatic biopsies. Under investigation is the modi-
fication of the number and site of core biopsies taken [13, 14],
and mathematical models for the correct number of core
biopsies per patient were established [15].
In this prospective study, extended systematic sextant biopsies
of the prostate – extended with 4 additional biopsies of the
transition zone – were done on patients with a suspicion of
CaP. In the study performed herein, biopsy was ultrasound-
guided, and if irregular ultrasound findings were present,
Histological Ultrasonographical tissue appearance in patients with negative DRE (n =166)
result isodense hypoechoic hyperechoic mixed-echoic anechoic total
Benign
Biopsy cores
Number 1,137 98 72 105 98 1,510
Expected*, n 1,122.5 113.7 71.0 109.2 93.7 1,510.0
Histology, % 75.3 6.5 4.8 7.0 6.5 100.0
Ultrasound, % 92.1 78.4 92.3 87.5 95.1 91.0
PIN
Biopsy cores
Number 48 11 1 5 5 70
Expected*, n 52.0 5.4 3.3 5.1 4.3 70.0
Histology, % 68.6 15.7 1.4 7.1 7.1 100.0
Ultrasound, % 3.9 8.8 1.3 4.2 4.9 4.2
CaP
Biopsy cores
Number 49 16 5 10 0 80
Expected*, n 59.5 6.0 3.8 5.8 5.0 80.0
Histology, % 61.3 20.0 6.3 12.5 0.0 100.0
Ultrasound, % 4.0 12.8 6.4 8.3 0.0 4.8
Total
Biopsy cores
Number 1,234 125 78 120 103 1,660
Expected*, n 1,234.0 125.0 78.0 120.0 103.0 1,660.0
Histology, % 74.3 7.5 4.7 7.2 6.2 100.0
Ultrasound, % 100.0 100.0 100.0 100.0 100.0 100.0
*Expected by chi-square test.
Table 3. Results of each core biopsy of the
prostate of patients with negative findings in
digital rectal examination in relation to the
sonographically determined appearance of the
area biopsied in correlation to statistical 
analysis (chi-square test)
Table 4. Results of histological examination in patients with biopsy cores
taken from areas that appear sonographically hypoechoic; distribution to
peripheral (PZ) and transition zone (TZ)
Hypoechoic pattern CaP Benign
in sonography histology
Only TZ, n 4 (+ 3*) 16
Only PZ, n 19 ( + 6*) 45
TZ + PZ, n 22 15
Total, n 54 76
*3 and 6 patients, respectively, had a hypoechoic ultrasound pattern and
CaP, but the tumor was detected in other regions of the prostate.
Ultrasound Findings in the Prostate Suspicious 
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biopsy cores were directly taken from the suspicious lesion.
This is in contrast to the standard sextant biopsy technique,
where ultrasound is only used to receive randomized biopsy
cores. For each biopsy core, the predominant ultrasound
pattern was documented and analyzed in relation to the histo-
logical result of the corresponding biopsy core.The intention of
the present study was to evaluate the importance of prostatic
ultrasound findings other than isoechoic.
It is generally accepted that prostatic biopsy is indicated in
patients with a PSA elevation > 4 ng/ml or with palpable
abnormalities of the prostate. In addition, it is accepted that
hypoechoic areas that can be recognized on transrectal ultra-
sound examination of the prostate are often associated with
the presence of CaP. The mere presence of any hypoechoic
lesions in the peripheral zone is stated to be associated with a
sensitivity of 86% and a specificity of 45% for the detection of
CaP [5]. Considering TRUS as suspicious when a hypoechoic
lesion was present anywhere in the prostate, the sensitivity of
hypoechoic lesions for the presence of CaP was 62.1% and the
specificity was 57.3% in the present study. Analysis for each
core biopsy with isoechoic ultrasound pattern revealed CaP in
7.6% of biopsy cores only, whereas an echogenicity other than
isoechoic was associated with a much higher rate of CaP de-
tected (table 1). Cancer diagnosis was increased most when
biopsying hypoechoic lesions with a detection rate of 34.5%.
But also taking biopsies from regions of hyperechoic or mixed-
echoic ultrasound appearance resulted in the detection of CaP
in 26.9 and 21.1%, respectively.
TRUS findings were examined in relation to DRE results by
Devonec et al. [16]. In that study, 64 patients had a palpable
nodularity on DRE, and CaP was found in 34 patients (53%).
All 64 patients in the study of Devonec et al. had an abnormal
hypoechoic lesion on the transrectal scan. In our series, 99 pa-
tients had s suspicious finding on DRE and 52 (59.7%) had
CaP. 61 patients (61.6%) of the 99 patients with positive DRE
had hypoechoic lesions. In this subgroup, CaP was detected in
36 patients (59.0%). Devonec et al. had 162 (27%) of 602 pa-
tients with a negative DRE and a hypoechoic lesion on the
TRUS exam, and all of them were biopsied. Histological
examination revealed CaP in 11 of these patients (6.7%).
Thus, the rate of hypoechoic lesions representing CaP (45 of
226 patients) found in the study of Devonec et al. was lower
than the rate in our study (45 of 130 patients) (19.9 and 34.6%,
respectively).
Norberg et al. [17] examined 512 men with the suspicion of CaP
and found suspicious (hypo-, hyperechoic and irregular) ultra-
sound lesions in 328 (64.1%) patients regardless of the DRE
findings. CaP was detected in 276 patients (53.9%). In that
series, CaP corresponding to the TRUS findings was present 
in 57%. 11% of the men in the study of Norberg et al. with 
hypo-/hyperechoic/irregular lesions had their cancer elsewhere
in the gland. In another study by Cooner et al. [6], hypoechoic
lesions were seen in the prostate less frequently [835 out of
1,807 patients (46.2%)]. In all 835 cases guided biopsies of 
the suspicious lesions were performed, and CaP was found in
263 patients (31.5%); 260 of these lesions were identified in the
peripheral or central zones, whereas only 3 cases (1.1%) of CaP
could be detected in the transition zone. This is in contrast to
our study, in which 22.6% of the 265 patients had hypoechoic
lesions in the transition zone, who were classified to be sus-
picious for CaP. In 48.3% of these patients, biopsy proved posi-
tive for CaP. Supported by the data of McNeal et al. [18] who
showed that CaP develops in the transition zone in about 24%
of all prostatic carcinomas, the number of CaPs detected in 
the transition zone seems to be rather low and perhaps may 
be ascribed to the transition zone biopsy technique used by
Cooner and co-workers [6].
In most studies, however, randomized transition zone biopsies
were performed and suspicious areas were not directly
biopsied as the transition zone is somewhat more hypoechoic
in comparison to the peripheral zone. In the present study,
pronounced hypoechoic ultrasound patterns were found less
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Fig. 1. Error bar charts for mean values of hypoechoic (a) and all suspect ultrasound findings (b) per patient and different histological results with 95%
confidence intervals. a and b p = 0.000 for differences between groups.
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frequently in the transition zone than in the peripheral zone,
but hypoechoic lesions were associated with CaP in the tran-
sition zone in 20% and in the peripheral zone in 29.7%.
Under the condition that hypoechoic lesions were present in
both peripheral and transition zones, CaP was detected in
59.5%. In our opinion, pronounced hypoechoic lesions in the
transition zone therefore have to be taken into account when
suspecting CaP.
The present study also shows a high number of CaP in hyper-
echoic and echo-mixed/irregular lesions. Although there are
some studies in which hyperechoic areas have been found to be
associated with CaP, exact data with new ultrasound technique
are not available. The majority of examiners assess only hypo-
echoic areas as suspicious for CaP. Most prostate biopsy studies
do not directly relate to the echogenicity of the prostatic tissue,
and it is not always clear whether all suspicious prostatic lesions
or hypoechoic lesions only were biopsied. In the present study
all suspicious lesions, i.e. areas appearing not isoechoic, were
biopsied, and in all patients 10 core biopsies, representative 
of the peripheral and the transition zone, were taken. As a
result, the number of lesions per prostate classified as of hypo-,
hyper- or mixed-echoic appearance could be identified as pre-
dictive for CaP. Thus, when taking into account all suspicious
ultrasound patterns and the number found in each patient, this
could be helpful in avoiding repeated unnecessary prostatic
biopsies.
In conclusion, echogenicity in prostatic ultrasound is highly
informative, and guided biopsies may increase the rate of 
CaP detected. Although hypoechoic lesions in transrectal
ultrasound are most often associated with the presence of
CaP, hyperechoic lesions and lesions with a mixed/irregular
ultrasound appearance contain the 3- to 4-fold number of
CaP in comparison to isoechoic (normal) prostatic tissue.
In addition, transition zone ultrasound shows hypoechoic
lesions less frequently, but when seen, transition zone hypo-
echogenicity is associated with CaP in nearly the same fre-
quency as in the peripheral zone. From our data, directed
biopsies of irregular ultrasound findings with a modern ultra-
sound equipment seem to be advisable to increase the detec-
tion rate of CaP.
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